Samuel J. Klempner, MD
Medical Oncologist
Dr. Samuel Klempner graduated from the University of Massachusetts Medical School and completed his residency program at the Brigham and Women's Hospital. Then, he did a fellowship at the Beth Israel Deaconess Medical Center. He is specialized in Medical Oncology and is board certified in Internal Medicine, Hematology and Oncology. Dr. Klempner has been in practice for more than 6 years and is affiliated with the Brigham and Women's Hospital and Cedar-Sinai Medical Center. During his career, he has also contributed to several clinical research publications.
University of Massachusetts Medical School
Medical School
Brigham and Women\'s Hospital
Residency
Beth Israel Deaconess Medical Center
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
CA State Medical License 2013 - 2018
Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers.
Wei, R. L.,Jung, B. C.,Manzano, W.,Sehgal, V.,Klempner, S. J.,Lee, S. P.,Ramsinghani, N. S.,Lall, C.; Radiother Oncol. 1900 Jan 01.
See more >>A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.
Kodityal, S.,Elvin, J. A.,Squillace, R.,Agarwal, N.,Miller, V. A.,Ali, S. M.,Klempner, S. J.,Ou, S. H.; Lung Cancer. 2016 Jan 19.
See more >>Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach.
Lee, J.,Tran, P.,Klempner, S. J.; Clin Oncol (R Coll Radiol). 2016 Feb 18.
See more >>Alpha Omega Alpha Honor Medical Society
American Association for Cancer Research
American Society of Clinical Oncology